Everlight Responds to Chinese Court Verdict in Nichia's Favor

In response to Nichia Corporation’s  press release on November 7th regarding Chinese Patent Nos. ZL97196762.8 and ZL03159595.2 (YAG patents). Nichia’s YAG patents are only partially valid after claim amendments during the invalidity proceedings. Such narrower scopes of patent claims consequently have no effect on Everlight’s product portfolio.


Nichia lost both civil and administrative actions it filed in Taiwan in 2011 with final judgments. Everlight strives to develop diverse products and currently holds more than 1600 patents. Everlight will strengthen its patent portfolio in order to protect the rights of its clients and shareholders.
 

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein<
Proprietary Rights
You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.

Tokushima, Japan - 6 March 2024: Nichia, the world's largest LED manufacturer and inventor of the high-brightness blue and white LED, has started mass production of the new UV-B (308nm) and UV-A (330nm) LEDs in its popular 434 Series packa... READ MORE

New XLamp® S Line LEDs enhance growth, last longer, lower energy costs Horticulture and other forms of agricultural lighting require application-tuned ratios of spectral content, high efficacy and long lifetimes. Whether you are interested... READ MORE